What is TuHURA Biosciences, Inc.'s payments for finance leases?

TuHURA Biosciences, Inc. (HURA) reported payments for finance leases of $10.85K in Q1 2026.

What does payments for finance leases mean?

Principal payments on finance lease obligations, reducing the lease liability on the balance sheet.

ImmunityBio, Inc.IBRX

$13K—

Revenue-—

Net income-$7.5M-13.1%

EPS (diluted)-$0.13+13.3%

Cash & equivalents$6.3M+1.3%

Total debt$456.9K+178%

Total equity$23.2M+135%

Total assets$29.7M+103%

Operating cash flow-$4.4M+6.9%

CapEx$48.8K+14.5%

Free cash flow-$4.5M+6.7%

Market cap$155.39M+45.8%

Enterprise value$149.54M+52.3%

Return on equity-187.2%—

Debt / equity0×0.0×

Current ratio1.2×-1.8×

Reported directly by TuHURA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.

The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is TuHURA Biosciences, Inc.'s payments for finance leases?: TuHURA Biosciences, Inc. (HURA) reported payments for finance leases of $10.85K in Q1 2026.
What does payments for finance leases mean?: Principal payments on finance lease obligations, reducing the lease liability on the balance sheet.